Advances in the carbonic anhydrase (CA, EC 4.2. 1.1) research over the last three decades are presented, with an emphasis on the deciphering of the activation mechanism, the …
C Kakakhan, C Türkeş, Ö Güleç, Y Demir… - Bioorganic & Medicinal …, 2023 - Elsevier
Abstract A novel series of 1, 2, 3-triazole benzenesulfonamide substituted 1, 3- dioxoisoindolin-5-carboxylate (7a-l) inhibitors of human α-carbonic anhydrase (hCA) was …
Sulfonamides are among the most promising potential inhibitors for carbonic anhydrases (CAs), which are pharmaceutically relevant targets for treating several disease conditions …
During the past three decades, mice, zebrafish, fruit flies, and Caenorhabditis elegans have been the primary model organisms used for the study of various biological phenomena …
CT Supuran - Expert opinion on drug discovery, 2017 - Taylor & Francis
Introduction: The enzyme carbonic anhydrase (CA, EC 4.2. 1.1) is found in numerous organisms across the tree of life, with seven distinct classes known to date. CA inhibition can …
The tumor microenvironment is crucial for the growth of cancer cells, triggering particular biochemical and physiological changes, which frequently influence the outcome of …
V Alterio, A Di Fiore, K D'Ambrosio, CT Supuran… - Chemical …, 2012 - ACS Publications
Carbonic anhydrases (CAs, EC 4.2. 1.1) are ubiquitous metallo-enzymes, present throughout most living organisms and encoded by five evolutionarily unrelated gene …
D Neri, CT Supuran - Nature reviews Drug discovery, 2011 - nature.com
The high metabolic rate of tumours often leads to acidosis and hypoxia in poorly perfused regions. Tumour cells have thus evolved the ability to function in a more acidic environment …
CT Supuran - Expert opinion on investigational drugs, 2018 - Taylor & Francis
Introduction: Hypoxic tumors overexpress two carbonic anhydrases (CA, EC 4.2. 1.1), CA IX and XII, involved in complex processes connected to tumorigenesis (pH regulation …